Quintrio
Home

HOSPITAL & MEDICAL SERVICE PLANS

Oscar Health, Inc.

OSCR

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

Last trade $30.25
Day change -$1.08 (-3.45%)
Day range $30.11 – $31.67
Volume 1,990,867
Market cap $9.73B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$9.73B
Price / earnings
11.38×
Price / book
4.38×
Price / sales
0.56×
EV / sales
0.33×
EV / EBITDA
7.47×

Profitability

Earnings per share
$2.75
Return on assets
8.55%
Return on equity
38.49%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.19×
Current ratio
1.14×
Quick ratio
1.14×
Cash ratio
0.61×

Cash flow

Price / cash flow
2.33×
Price / free cash flow
2.35×
Free cash flow
$4.14B

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for OSCR, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$5.05B$4.88B$4.59B$2.76B$2.93B$2.86B$3B$2.35B
Cost of revenue$4.23B$3.79B$3.23B$2.62B$2.59B$2.55B$2.26B$2.07B
Gross profit$815.44M$1.09B$1.36B$135.55M$346.44M$310.97M$740.5M$284.9M
Selling, general and administrative$728.44M$697.14M$713.25M$518.91M$528.9M$541.46M$489.49M$475.05M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$728.44M$697.14M$713.25M$518.91M$528.9M$541.46M$489.49M$475.05M
Operating income$87M$388.64M$643.47M-$383.36M-$182.47M-$230.48M$251.01M-$190.15M
Interest expense-$4.73M-$4.71M-$5.38M$1.1M-$6.86M-$5.85M-$5.99M-$6.03M
Income before taxes$175.38M$383.01M$698.77M-$352.68M-$139.29M-$233.54M$288.21M-$153.69M
Income taxes$8.08M$21.18M$19.75M-$247K-$1.81M-$5.05M$12.71M-$404K
Net income$167.3M$361.83M$679.02M-$352.43M-$137.48M-$228.49M$275.51M-$153.29M
Net income attributable to common shareholders$167.28M$361.81M$679M-$352.61M-$137.45M-$228.36M$275.27M-$153.55M
EBITDA$93.55M$394.67M$650.49M-$375.48M-$175.15M-$223.51M$257.74M-$180.92M
Basic earnings per share$0.54$1.20$2.28-$1.24-$0.53-$0.89$1.10-$0.62
Diluted earnings per share$0.49$1.10$2.07-$1.54-$0.53-$0.89$0.92-$0.69

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Best Growth Stocks to Buy for November 16th

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings as of November 16: Hasbro (HAS) in entertainment with 14.1% earnings estimate increase, MongoDB (MDB) in database platforms with a strong Growth Score of A, and Oscar Health (OSCR) in healthcare technology with a notable 61% earnings estimate increase over the last 60 days.

Zacks Investment Research

Best Growth Stocks to Buy for November 12th

Zacks highlights three stocks with Rank #1 buy ratings and strong growth potential: MongoDB, a database software company with a Growth Score of A; Ingram Micro, an IT distribution company with 6.2% earnings estimate increase; and Oscar Health, a healthcare technology company with a 61% earnings estimate increase over the last 60 days.

Zacks Investment Research

Here's Why CNO Financial Can Be a Smart Addition to Your Portfolio

CNO Financial Group (CNO) has outperformed its industry with a 39.4% stock gain over the past year, driven by sustained sales growth across Medicare Supplement, life, and health products. The company raised its 2026 operating EPS guidance to $5.05-$5.15 and reported its 17th consecutive quarter of sales growth. However, investors should monitor elevated morbidity claims, high leverage (debt-to-capital at 66.1%), and annuity earnings uncertainty.

Zacks Investment Research

Best Growth Stocks to Buy for November 10th

Zacks highlights three stocks with Rank #1 buy ratings and strong growth potential: MongoDB, a database software company with a PEG ratio of 2.20 and Growth Score A; Ingram Micro, an IT distribution company with a PEG ratio of 0.58 and Growth Score A; and Oscar Health, a healthcare technology company with a PEG ratio of 0.27 and a notable 35.1% earnings estimate increase over 60 days.

The Motley Fool

Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress.

With Democrats potentially returning to power in Congress, health insurers focused on the ACA marketplace like Oscar Health and Centene could benefit from restored government subsidies for lower-income payers. These subsidies expired earlier in 2026, causing significant member churn. Healthcare cost inflation and potential subsidy reinstatement could drive premium growth and profitability for these insurers, though risks include potential nationalized health insurance policies.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.